COMMUNIQUÉS West-GlobeNewswire

AB Science annonce aujourd’hui ses résultats financiers semestriels au 30 juin 2019 et présente un point sur ses activités
30/09/2019
Paris, 30 septembre 2019, 20h Perte nette de 13M€ au premier semestre 2019 Déficit opérationnel de 10,6 M€, soit une réduction des dépenses de 25,5% par rapport au premier semestre 2018 (14,2M€) Trésorerie de 2,7M€ au [...]
Predictive Oncology Inc. Announces Repayment or Extension of Promissory Notes due September 28, 2019
30/09/2019
MINNEAPOLIS, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive” or “the Company”) today announced that its secured promissory notes that were due September 28, 2019 have been repaid [...]
Assertio Therapeutics Announces Appointment of Dr. David Wheadon to its Board of Directors
30/09/2019
LAKE FOREST, Ill., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that Dr. David Wheadon has been appointed to the Company’s Board of Directors. Dr. Wheadon is a former [...]
Theratechnologies to Present at Cantor Fitzgerald Global Healthcare Conference in New York City
30/09/2019
MONTREAL, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Philippe Dubuc, Senior Vice President and Chief Financial Officer will make a presentation at [...]
Le chef de la direction financière assistera au Cantor Fitzgerald Global Healthcare Conference à New York
30/09/2019
MONTRÉAL, 30 sept. 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que Philippe Dubuc, vice-président senior et chef de la direction financière, fera une [...]
Cronos Group Announces Appointment of Jody Begley to Board of Directors
30/09/2019
TORONTO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that, in connection with its investment in the Company, Altria Group, Inc. (“ [...]
Molina Healthcare Announces Third Quarter 2019 Earnings Release and Conference Call Dates
30/09/2019
Long Beach, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the third quarter ended September 30, 2019. Molina Healthcare will [...]
CV Sciences Applauds House Passage of the SAFE Banking Act of 2019
30/09/2019
The SAFE Banking Act Provides the Cannabis Industry Access to Banking and Financial Services SAN DIEGO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we [...]
Resignation of JSC Olainfarm member of the Management Board
30/09/2019
JSC Olainfarm has received the letter of resignation from Veranika Dubitskaya whereby she steps down from her duties as a member of the Management Board as of 30 September 2019. JSC Olainfarm Management Board continues [...]
First Substantial Customer: Tennessee Oncology Internalizes Precipio’s HemeScreen™
30/09/2019
Following completion of a successful validation testing, laboratory set to launch assay NEW HAVEN, Conn., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that [...]
Nature Biotechnology Study Reveals That Tempus’ xT Platform Increases Cancer Patients’ Personalized Therapeutic Opportunities
30/09/2019
CHICAGO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today published a study in Nature [...]
Total number of shares and voting rights in Zealand Pharma at September 30, 2019
30/09/2019
Company announcement – No. 36 / 2019 Total number of shares and voting rights in Zealand Pharma at September 30, 2019 Copenhagen, September 30, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78 [...]
New Report Sheds Light on Japan’s Digital Healthcare Economy
30/09/2019
Commonalities between the UK and Japan exist, and a new whitepaper gives insights into the areas of data, digitisation and collaboration LONDON, Sept. 30, 2019 (GLOBE NEWSWIRE) -- HIMSS, a global advisor and thought [...]
Data from Agios’ Phase 3 ClarIDHy Trial of TIBSOVO® Demonstrates Significant Improvement in Progression Free Survival (PFS) Compared to Placebo in Previously Treated IDH1 Mutant Cholangiocarcinoma Patients
30/09/2019
– TIBSOVO ® Reduced the Risk of Disease Progression or Death by 63% (HR=0.37, p<0.001); Median PFS for Patients Randomized to TIBSOVO ® was 2.7 months Compared to 1.4 Months with Placebo – – TIBSOVO ® Patients Had 6- [...]
Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer
30/09/2019
New England Journal of Medicine publishes data showing improved survival with Jevtana ® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer CARD is a treatment [...]
Sanofi : Le New England Journal of Medicine publie des données montrant que Jevtana® (cabazitaxel) améliore la survie comparativement à un agent ciblant le récepteur des androgènes de deuxième ligne dans le traitement du cancer de la prosta
30/09/2019
Le New England Journal of Medicine publie des données montrant que Jevtana ® (cabazitaxel) améliore la survie comparativement à un agent ciblant le récepteur des androgènes de deuxième ligne dans le traitement du cancer [...]
Roche presents positive Phase III results for Tecentriq® (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer
30/09/2019
IMvigor130 is the first positive Phase III study of a cancer immunotherapy combination in people with previously untreated advanced bladder cancer Tecentriq combination reduced the risk of disease worsening or death ( [...]
Novo Nordisk A/S – Share repurchase programme
30/09/2019
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 30 September 2019 – On 9 August 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the [...]
Generex Biotechnology Subsidiary Olaregen Therapeutix Signs National Sales & Distribution Agreement With AvKare Medical to Distribute Excellagen® Throughout the VA Hospital System
30/09/2019
AvKare Medical, a Service-Disabled Veteran-Owned Small Business (SDVOSB), is a leading distributor of healthcare products Nationwide distribution and direct sales force to more than 170 VA medical centers and government [...]

Pages